119 related articles for article (PubMed ID: 35005862)
1. Efficacy and Tolerability of a Double-Conjugated Retinoid and Alpha Hydroxy Acid Cream in Subjects With Mild to Moderate Blemish-Prone Skin.
Robinson D; Friedmann D; Gordon J; Wortzman M; Nelson D
J Drugs Dermatol; 2022 Jan; 21(1):54-59. PubMed ID: 35005862
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and Tolerability of a Retinoid Eye Cream for Fine to Moderate Wrinkles of the Periorbital Region.
Kaufman J; Callender V; Young C; Jones P; Wortzman M; Nelson D
J Drugs Dermatol; 2022 Sep; 21(9):932-937. PubMed ID: 36074511
[TBL] [Abstract][Full Text] [Related]
3. In Vitro and In Vivo Efficacy and Tolerability of a Non-Hydroquinone, Multi-Action Skin Tone Correcting Cream.
Grimes PE; McDaniel DH; Wortzman M; Nelson D
J Drugs Dermatol; 2019 Jul; 18(7):642-648. PubMed ID: 31329402
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and tolerability of a double-conjugated retinoid cream vs 1.0% retinol cream or 0.025% tretinoin cream in subjects with mild to severe photoaging.
McDaniel DH; Mazur C; Wortzman MS; Nelson DB
J Cosmet Dermatol; 2017 Dec; 16(4):542-548. PubMed ID: 28762645
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of an advanced antioxidant and double-conjugated retinoid/AHA cream in participants with FST IV-V.
Grimes PE; Nelson DB
J Cosmet Dermatol; 2024 Apr; 23(4):1291-1297. PubMed ID: 38406974
[TBL] [Abstract][Full Text] [Related]
6. Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate and Severe Acne Vulgaris in Females: Effect of Age on Efficacy and Tolerability.
Stein Gold L; Pariser DM; Guenin E
J Drugs Dermatol; 2019 Dec; 18(12):1218-1225. PubMed ID: 31860209
[TBL] [Abstract][Full Text] [Related]
7. A pilot study evaluating the efficacy and tolerability of a comprehensive, hydrating topical antioxidant developed specifically for men.
Sikora BC; Wortzman M; Nelson DB; Dover JS
J Cosmet Dermatol; 2021 Sep; 20(9):2816-2823. PubMed ID: 34189833
[TBL] [Abstract][Full Text] [Related]
8. Novel Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris in an Asian Population.
Han G; Armstrong AW; Desai SR; Guenin E
J Drugs Dermatol; 2019 Sep; 18(9):910-916. PubMed ID: 31524347
[TBL] [Abstract][Full Text] [Related]
9. Tazarotene 0.045% Lotion for the Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris in Adult Males.
Cook-Bolden FE; Gold MH; Guenin E
J Drugs Dermatol; 2020 Jan; 19(1):78-85. PubMed ID: 32023013
[TBL] [Abstract][Full Text] [Related]
10. A Double-Blind, Comparative Clinical Study of Newly Formulated Retinol Serums vs Tretinoin Cream in Escalating Doses: A Method for Rapid Retinization With Minimized Irritation.
Draelos ZD; Peterson RS
J Drugs Dermatol; 2020 Jun; 19(6):625-631. PubMed ID: 32574009
[TBL] [Abstract][Full Text] [Related]
11. A Phase 2b, Randomized, Double-Blind Vehicle Controlled, Dose Escalation Study Evaluating Clascoterone 0.1%, 0.5%, and 1% Topical Cream in Subjects With Facial Acne.
Mazzetti A; Moro L; Gerloni M; Cartwright M
J Drugs Dermatol; 2019 Jun; 18(6):570. PubMed ID: 31251550
[TBL] [Abstract][Full Text] [Related]
12. Novel Tretinoin 0.05% Lotion for Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris in a Hispanic Population.
Cook-Bolden FE; Weinkle SH; Guenin E; Bhatt V
J Drugs Dermatol; 2019 Jan; 18(1):32-38. PubMed ID: 30681791
[TBL] [Abstract][Full Text] [Related]
13. Tazarotene 0.045% Lotion for Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris: Results from Two Phase 3 Trials.
Tanghetti EA; Werschler WP; Lain T; Guenin E; Martin G; Pillai R
J Drugs Dermatol; 2020 Jan; 19(1):70-77. PubMed ID: 31985914
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a Neck Cream Developed to Enhance Nitric Oxide Availability in Aging Skin.
Mraz Robinson D; Kaufman J; Giannini A; Minhaj Rahman S; Wortzman M; Nelson DB
J Drugs Dermatol; 2023 Sep; 22(9):881-886. PubMed ID: 37683057
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and Tolerability of a Novel Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate or Severe Acne Vulgaris in Adult Females.
Harper JC; Baldwin H; Stein Gold L; Guenin E
J Drugs Dermatol; 2019 Nov; 18(11):1147-1154. PubMed ID: 31741360
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of a hyaluronic acid-based serum and a peptide-rich cream for the face and neck in subjects with photodamaged skin.
Gold MH; Biron JA; Wilson A; Nelson DB
J Cosmet Dermatol; 2022 Aug; 21(8):3458-3463. PubMed ID: 35426967
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and Tolerability of Topical 0.1% Stabilized Bioactive Retinol for Photoaging: A Vehicle-Controlled Integrated Analysis.
Farris P; Berson D; Bhatia N; Goldberg D; Lain E; Mariwalla K; Zeichner J; Miller D; McGuire T; Kizoulis M
J Drugs Dermatol; 2024 Apr; 23(4):209-215. PubMed ID: 38564380
[TBL] [Abstract][Full Text] [Related]
18. Anti-aging proof of concept study: results and summary.
Bruce S; Karnik J; Dryer L; Burkholder D
J Drugs Dermatol; 2014 Sep; 13(9):1074-81. PubMed ID: 25226008
[TBL] [Abstract][Full Text] [Related]
19. An Evaluation of Efficacy and Tolerability of Novel Enzyme Exfoliation Versus Glycolic Acid in Photodamage Treatment.
Mekas M; Chwalek J; MacGregor J; Chapas A
J Drugs Dermatol; 2015 Nov; 14(11):1306-19. PubMed ID: 26580881
[TBL] [Abstract][Full Text] [Related]
20. An evaluation of the benefits of a topical treatment in the improvement of photodamaged hands with age spots, freckles, and/or discolorations.
Gold MH; Gallagher C
J Drugs Dermatol; 2013 Dec; 12(12):1468-72. PubMed ID: 24301250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
